How We Treat Recurrent Glioblastoma Today and Current Evidence
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-019-0834-y.pdf
Reference46 articles.
1. • Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, et al. Lomustine and bevacizumab in progressive glioblastoma. N Engl J Med. 2017;377(20):1954–63. https://doi.org/10.1056/NEJMoa1707358 . The first published phase 3 trial with BEV in rGBM and did not show any gain in OS or in quality of life. However, FDA kept the appoval of BEV for rGBM.
2. •• Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499–508. https://doi.org/10.1056/NEJMoa1407279 . Published in New England Journal of Medicine , it was one of the most downloaded article in 2015. Some of these mutations were incorporated to WHO tumor classification.
3. Brzozowska A, Toruń A, Mazurkiewicz M. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme. Adv Clin Exp Med. 2015;24(2):279–87. https://doi.org/10.17219/acem/40456 .
4. Sastry RA, Shankar GM, Gerstner ER, Curry WT. The impact of surgery on survival after progression of glioblastoma: a retrospective cohort analysis of a contemporary patient population. J Clin Neurosci. 2018;53:41–7. https://doi.org/10.1016/j.jocn.2018.04.004 .
5. • Ringel F, Pape H, Sabel M, Krex D, Bock HC, Misch M, et al. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol. 2016;18(1):96–104. https://doi.org/10.1093/neuonc/nov145 . Positive results regarding re-resection in rGBM, with a robust numer of patients.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utility of a Novel Exoscope, ORBEYE, in Re-resection for Recurrent Brain Tumor;Interdisciplinary Neurosurgery;2023-12
2. Monte Carlo-based optimization of glioma capsule design for enhanced brachytherapy;Applied Radiation and Isotopes;2023-11
3. Nanobiotechnology-based treatment strategies for malignant relapsed glioma;Journal of Controlled Release;2023-06
4. Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?;Cancers;2022-11-09
5. Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma;Journal of Cancer Research and Clinical Oncology;2022-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3